Understanding the pathophysiology of MMM overlap syndrome is crucial for implementing targeted immunosuppressive treatment in cases mediated by complement or PD-1/PD-L1 axis disruption. The gene discussed is PDCD1; the disease is myelofibrosis with myeloid metaplasia.